Consolidated Strategic Information Guidelines for Viral Hepatitis: Planning and Tracking Progress towards Elimination. WHO. (2019)

image

The Consolidated strategic information guidelines for viral hepatitis summarize and simplify the overall approach proposed by WHO to collect, analyse, disseminate and use strategic information on viral hepatitis at local, subnational, national and international levels.

The document describes the use of strategic information at various stages of the response in the context of strengthening broader health information systems. Strategic information can be defined as data collected at all service delivery and administrative levels to inform policy and programme decisions.

 

Keywords: HBV and HCV, health system, surveillance


Download Documents


- Guidelines


- Annex 1: Standard Operating Procedures for Enhanced Reporting of Cases of Acute Hepatitis


- Annex 2: Template Protocol for Surveys to Estimate the Prevalence of Biomarkers of Infection with the Hepatitis Viruses: Tool for Adaptation and Use at Country Level 


- Annex 3: Protocol for Surveillance of the Fraction of Cirrhosis and Hepatocellular Carcinoma Attributable to Viral Hepatitis in Clinical Centres of Excellence 

The Privacy, Confidentiality and Security Assessment Tool — User Manual. UNAIDS. (2019)

image

Based on privacy, confidentiality and security principles an Assessment Tool was developed to assess in country the extent that the confidentiality and security of personal health information is protected at facility and data warehouse/repository levels and whether national guidelines exist including privacy laws. A Manual on the use of the Assessment Tool has been produced and is available below. 


Keywords: HIV, health services, confidentiality and security

 

 

Download Document

The Privacy, Confidentiality and Security Assessment Tool: Protecting Personal Health Information. UNAIDS. (2019)

image

With scaling-up of HIV and other health services in low- and middle-income countries, an increasing amount of personally identifiable health information is being collected at health facilities and stored in data repositories at local, regional and national levels. Countries need to protect the confidentiality and security of identifiable and de-identified personal health information, and this can be accomplished in part through the existence and implementation of relevant privacy laws, policies and programmes.


Keywords: HIV, health services, confidentiality and security

 

Download Document 

WHO Guidelines on Tuberculosis Infection Prevention and Control, 2019 Update. WHO. (2019)

image

These guidelines have been developed to provide updated, evidence-informed recommendations on tuberculosis (TB) infection prevention and control (IPC) in the context of the global targets of the Sustainable Development Goals (SDGs) and the World Health Organization (WHO) End TB Strategy. The notion and practice of IPC encompasses a set of broader, practical, evidence-based approaches to preventing the community from being harmed by avoidable infections, preventing health care-associated infections (HAI), implementing laboratory biosafety and reducing the spread of antimicrobial resistance (AMR). 


Keywords: TB, policy, health care, interventions

 

 

Download Publication

Guidelines for the Care and Treatment of Persons Diagnosed with Chronic Hepatitis C Virus Infection. WHO. (2018)

image

These guidelines aim to provide evidence-based recommendations on the care and treatment of persons diagnosed with chronic HCV infection. They update the care and treatment section of the WHO Guidelines for the screening, care and treatment of persons with hepatitis C infection issued in April 2016. The 2017 Guidelines on hepatitis B and C testing update the screening section.


Keywords: HCV, HIV, co-infection, transmission, treatment 

 

 

Download Document

Guidelines on the Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-infected Adults, Adolescents and Children. WHO. (2018)

image

These guidelines provide recommendations and good practice guidance on the optimal approach to diagnosing cryptococcal meningitis, strategies for preventing invasive cryptococcal disease through cryptococcal antigen screening and pre-emptive fluconazole therapy, treating cryptococcal meningitis with combination antifungal therapy regimens, preventing, monitoring and managing amphotericin B drug toxicity, recommendations against adjunctive therapy with systemic corticosteroids and recommendations on the timing of antiretroviral therapy (ART) initiation.


Keywords: HIV, diagnosis, prevention, children, adults and adolescents

 

Download Document

Cascade Data Use Manual: To Identify Gaps in HIV and Health Services for Programme Improvement. WHO. (2018)

image

This guide supports the use of data to identify and fill gaps in services in order to improve HIV and health programmes. Following from the Consolidated Strategic Information Guidelines, high-level indicators are organized along a cascade of services which are linked to achieve outcomes. The guide supports the ways in which these cascade data are analysed and used to identify gaps and better link services.

 


Keywords: HIV, health services, care, treatment

 

Download Document

Data Quality Assessment of National and Partner HIV Treatment and Patient Monitoring Data and Systems Implementation Tool. WHO. (2018)

image

In the past decade, national programmes and donor-funded projects have made great progress in reaching people living with HIV with life-saving treatment in countries across the globe. Measuring success of these initiatives requires strong monitoring and evaluation systems that produce high-quality data.

Efforts to ensure data quality, therefore, are not singular events occurring randomly. Rather, these processes need to become institutionalized as part of all routine data management processes.

 

Keywords: HIV, data, assessment, monitoring system

 

Download Document

Guidance on Ethical Considerations in Planning and Reviewing Research Studies on Sexual and Reproductive Health in Adolescents. WHO. (2018)

image

This document is intended to address commonly occurring situations and challenges that one faces in carrying out research with adolescents (people aged 10–19 years), the majority of whom are deemed not to have reached the recognized age of majority in their respective settings. To this end, adolescents aged 18 and 19 years are classified as adults in many settings and have the legal capacity to make autonomous decisions regarding their participation in research. In this document, the term “children” refers to people below the age of 18 years, and the term “minor adolescents” refers specifically to people aged 10–18 years.

 

Keywords: sexual and reproductive health, adolescent, children

 

Download Publication

Guidelines for the Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-infected Adults, Adolescents and Children. WHO. (2018)

image

These guidelines provide recommendations and good practice guidance on the optimal approach to diagnosing cryptococcal meningitis, strategies for preventing invasive cryptococcal disease through cryptococcal antigen screening and pre-emptive fluconazole therapy, treating cryptococcal meningitis with combination antifungal therapy regimens, preventing, monitoring and managing amphotericin B drug toxicity, recommendations against adjunctive therapy with systemic corticosteroids and recommendations on the timing of antiretroviral therapy (ART) initiation.


Keywords: HIV, diagnosis, drugs, treatment

 

Download Guidelines and Policy Brief: Cryptococcal Disease

Pages

Data Dashboard
database
Highlighted publications
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_TB_Global_Report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-Global-AIDS-Update_Asia-Pacific_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-changing-laws-that-discriminate_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/PNG_HIV_National_Strategic_Information_2018-22.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/PNG_National_STI_and_HIV_Strategy.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-young-peoples-participation-in-community-based-responses-to-hiv_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNODC_factsheet_Ending_AIDS_by_2030_for_people_and_with_PUD_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_GAP_progress_report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HRI-women-harm-reduction-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Elective_C-section_should_not_be_routinely_recommended_to_WLHIV_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/ESCAP_Asia_and_the_Pacific_SDG_Progress_Report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guideline_on_digital_interventions_for_health_system_strengthening_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Progress_report_on_HIV_viral_hepatitis_and_STI_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV_UHC_Guide_Civil_Society_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_Annual_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV-related-travel-restrictions-explainer_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HIV-and-the-Law-supplement-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_IBBS_and_Population_size_estimates_among_FSW_2015.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_PWID_PWUD_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_FEW_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/DataHub_TB-HIV_Fact_Sheet_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
Calendar of events
Oct
11
Nov
14
Nov
20